Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts (scientific article published in Nature)

cites work (P2860)

Q58648634	Q58648634
Q35205665	"Second-generation" stem cells for cardiac repair
Q37109781	"Small stem cells" in adult tissues: very small embryonic-like stem cells stand up!
Q28084360	"The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cells
Q26825049	10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice
Q36543846	7. Transplantation of undifferentiated, bone marrow-derived stem cells
Q41166315	A 3-D cardiac muscle construct for exploring adult marrow stem cell based myocardial regeneration
Q42914922	A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes
Q33719810	A Hyper-Crosslinked Carbohydrate Polymer Scaffold Facilitates Lineage Commitment and Maintains a Reserve Pool of Proliferating Cardiovascular Progenitors
Q37611644	A Novel Human Tissue-Engineered 3-D Functional Vascularized Cardiac Muscle Construct
Q39069176	A Novel View of the Adult Stem Cell Compartment From the Perspective of a Quiescent Population of Very Small Embryonic-Like Stem Cells
Q36904774	A challenge for regenerative medicine: proper genetic programming, not cellular mimicry
Q34116906	A crucial role of activin A-mediated growth hormone suppression in mouse and human heart failure
Q35762460	A decade of discoveries in cardiac biology
Q37483053	A heart full of stem cells: the spectrum of myocardial progenitor cells in the postnatal heart
Q28474773	A plant-derived remedy for repair of infarcted heart
Q28299027	A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow
Q42738342	A repair "kit" for the infarcted heart
Q26998969	A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods
Q46295022	A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction
Q35824092	A role for chemistry in stem cell biology
Q42688498	A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling.
Q89888187	Abcg2-expressing side population cells contribute to cardiomyocyte renewal through fusion
Q90632548	Absence of Cardiomyocyte Differentiation Following Transplantation of Adult Cardiac-Resident Sca-1+ Cells Into Infarcted Mouse Hearts
Q92840144	Absence of myocyte regeneration by mobilization of bone marrow stem cells after myocardial infarction
Q37057352	Accelerating skin wound healing by M-CSF through generating SSEA-1 and -3 stem cells in the injured sites
Q64084663	Acellular Extracellular Matrix Bioscaffolds for Cardiac Repair and Regeneration
Q36655337	Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease
Q37151499	Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury
Q41112375	Acute Catecholamine Exposure Causes Reversible Myocyte Injury Without Cardiac Regeneration.
Q34043802	Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis
Q27304355	Adipose Tissue-Derived Mesenchymal Stromal Cells Protect Mice Infected with Trypanosoma cruzi from Cardiac Damage through Modulation of Anti-parasite Immunity
Q33330259	Adult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardium
Q33225563	Adult bone marrow-derived cells: regenerative potential, plasticity, and tissue commitment
Q47338717	Adult skeletal muscle stem cells differentiate into endothelial lineage and ameliorate renal dysfunction after acute ischemia.
Q79390001	Adult stem cell plasticity: introduction to the first issue of stem cell reviews
Q37779933	Adult stem cells for cardiac tissue engineering
Q80758165	Adult stem cells: perspectives for therapeutic applications
Q91666691	Advancement in Stem Cell Therapy for Ischemic Myocardial Cell: A Systematic Review
Q41906508	Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy
Q50701050	Advances in cardiovascular molecular imaging for tracking stem cell therapy.
Q38843350	Advances in stem cell therapy for cardiovascular disease (Review).
Q33957120	Aesthetic cardiology: adipose-derived stem cells for myocardial repair
Q37310724	Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.
Q42949554	Amplification of coronary arteriogenic capacity of multipotent stromal cells by epidermal growth factor
Q35565809	An emerging consensus on cardiac regeneration
Q42861069	An imperfect syllogism: granulocyte colony-stimulating factor mobilization and cardiac regeneration
Q30480151	Angiomyogenesis for myocardial repair
Q34508351	Animal models of cardiac disease and stem cell therapy
Q36512731	Antiapoptotic effect of implanted embryonic stem cell-derived early-differentiated cells in aging rats after myocardial infarction
Q93089068	Application of Bioengineered Materials in the Surgical Management of Heart Failure
Q38938530	Arrhythmogenesis: a Roadblock to Cardiac Stem Cell Therapy.
Q37083700	Association of telomere shortening in myocardium with heart weight gain and cause of death
Q39514108	At a crossroad: cell therapy for cardiac repair
Q46824683	Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial
Q56610959	Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial
Q34563950	Autologous cardiomyotissue implantation promotes myocardial regeneration, decreases infarct size, and improves left ventricular function
Q37837891	Autologous cell therapy for cardiac repair.
Q53200230	BMP protein-mediated crosstalk between inflammatory cells and human pluripotent stem cell-derived cardiomyocytes.
Q92292792	Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology
Q42488789	Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts
Q36163604	Biological implications of cell fusion.
Q36596218	Biology of bone marrow-derived endothelial cell precursors
Q26852224	Biomaterials to enhance stem cell function in the heart
Q36737037	Biomimetic approach to cardiac tissue engineering
Q37872603	Bone Marrow - Home of Versatile Stem Cells.
Q38531024	Bone Marrow Therapies for Chronic Heart Disease
Q50946128	Bone Marrow Very Small Embryonic-Like Stem Cells: New Generation of Autologous Cell Therapy Soon Ready for Prime Time?
Q37783801	Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy
Q36132019	Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells.
Q36012911	Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells
Q37826666	Bone marrow cell injection for chronic myocardial ischemia: the past and the future
Q40348037	Bone marrow cell transfer in acute myocardial infarction
Q53316434	Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study).
Q33304156	Bone marrow cells adopt the cardiomyogenic fate in vivo
Q33379564	Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction
Q33254416	Bone marrow cells for cardiac regeneration and repair: current status and issues
Q35104607	Bone marrow mesenchymal stem cells are progenitors in vitro for inner ear hair cells
Q26821783	Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network
Q27006710	Bone marrow mononuclear cells and acute myocardial infarction
Q37194005	Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction.
Q28251098	Bone marrow stem cell transplantation for cardiac repair
Q42751683	Bone marrow tinctures for cardiovascular disease: lost in translation
Q33521715	Bone marrow transplantation results in human donor blood cells acquiring and displaying mouse recipient class I MHC and CD45 antigens on their surface
Q38166729	Bone marrow-derived cell therapy in chagasic cardiac disease: a review of pre-clinical and clinical results
Q34103630	Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair
Q37293770	Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart
Q36173615	Bone marrow-derived circulating progenitor cells fail to transdifferentiate into adipocytes in adult adipose tissues in mice
Q33202256	Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation
Q38233057	Bone marrow-derived mesenchymal cell differentiation toward myogenic lineages: facts and perspectives.
Q36520325	Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model
Q50653136	Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction.
Q36804551	Bone marrow-derived stem cell therapy in ischemic heart disease
Q36844563	Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study.
Q36819690	Bone marrow-derived very small embryonic-like stem cells: their developmental origin and biological significance
Q64084031	Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction
Q30557136	Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms
Q36999500	Bone-marrow-derived stem cells--our key to longevity?
Q37148741	Bones of contention: marrow-derived cells in myocardial regeneration
Q34574726	Bridging the regeneration gap: genetic insights from diverse animal models
Q41475459	CD133 Expression Strongly Correlates with the Phenotype of Very Small Embryonic-/Epiblast-Like Stem Cells
Q34125508	CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease
Q33927282	CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow
Q37967719	CD34-positive stem cells: in the treatment of heart and vascular disease in human beings
Q41125370	CMD kinetics and regenerative medicine
Q57951477	COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients After Acute Myocardial Infarction and Left Ventricular Dysfunction: Study Rationale and Design
Q28254272	CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice
Q27002443	Calcium signalling of human pluripotent stem cell-derived cardiomyocytes
Q33213658	Can a bone marrow cell contribute to organ regeneration? In vivo analysis using transgenic rats with reporter genes
Q38161754	Can stem cells really regenerate the human heart? Use your noggin, dickkopf! Lessons from developmental biology
Q39017865	Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells
Q36023234	Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases
Q34169758	Cardiac Function, Perfusion, Metabolism, and Innervation following Autologous Stem Cell Therapy for Acute ST-Elevation Myocardial Infarction. A FINCELL-INSIGHT Sub-Study with PET and MRI.
Q36146340	Cardiac Regeneration and Stem Cells.
Q41024149	Cardiac Stem Cells for Myocardial Regeneration: They Are Not Alone
Q90402112	Cardiac Stem Cells in the Postnatal Heart: Lessons from Development
Q80751107	Cardiac aid to the injured but not the elderly?
Q37800141	Cardiac cell therapies: the next generation
Q40053814	Cardiac cell therapy trials: chronic myocardial infarction and congestive heart failure
Q35144550	Cardiac cell therapy: where we've been, where we are, and where we should be headed
Q37092180	Cardiac cell-based therapy: cell types and mechanisms of actions
Q27303596	Cardiac engraftment of genetically-selected parthenogenetic stem cell-derived cardiomyocytes
Q37661493	Cardiac fibroblast-derived 3D extracellular matrix seeded with mesenchymal stem cells as a novel device to transfer cells to the ischemic myocardium
Q34334027	Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction
Q37767677	Cardiac progenitor cells: potency and control
Q38079141	Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research
Q30528601	Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart
Q35819367	Cardiac reconstruction in the Jurassic Period
Q35928368	Cardiac regeneration
Q37342538	Cardiac regeneration and stem cell therapy
Q26822619	Cardiac regeneration therapy: connections to cardiac physiology
Q34617472	Cardiac regeneration using pluripotent stem cells--progression to large animal models.
Q34643788	Cardiac regenerative capacity and mechanisms
Q90082403	Cardiac regenerative therapy: Many paths to repair
Q37253735	Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease
Q91291231	Cardiac repair and the putative role of stem cells
Q36349185	Cardiac repair by embryonic stem-derived cells
Q33406980	Cardiac repair with adult bone marrow-derived cells: the clinical evidence
Q24534652	Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction
Q46146747	Cardiac repair with thymosin β4 and cardiac reprogramming factors
Q36579504	Cardiac repair--fact or fancy?
Q35897332	Cardiac specification of embryonic stem cells.
Q37766145	Cardiac stem cell therapy and arrhythmogenicity: prometheus and the arrows of Apollo and Artemis
Q42575668	Cardiac stem cell therapy and the promise of heart regeneration
Q36488248	Cardiac stem cell therapy: present and future
Q38040206	Cardiac stem cell therapy: stemness or commitment?
Q36267790	Cardiac stem cells and mechanisms of myocardial regeneration
Q37182776	Cardiac stem cells and progenitors: developmental biology and therapeutic challenges.
Q35122190	Cardiac stem/progenitor cells, secreted proteins, and proteomics
Q83150650	Cardiac tissue engineering
Q37869908	Cardiac tissue engineering: a clinical perspective
Q41761869	Cardiac tissue engineering: a reflection after a decade of hurry
Q57071128	Cardiac tissue engineering: current state-of-the-art materials, cells and tissue formation
Q37423133	Cardiac tissue engineering: implications for pediatric heart surgery
Q37319214	Cardiogenic differentiation and transdifferentiation of progenitor cells
Q80028254	Cardiologists take heart from stem-cell treatment success
Q81386720	Cardiology: solace for the broken-hearted?
Q47951585	Cardiomyocyte Regeneration: A Consensus Statement
Q34725406	Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction
Q37832530	Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models
Q53468657	Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase.
Q38588589	Cardiomyocyte regeneration
Q29620480	Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts
Q36309565	Cardiomyocytes derived from stem cells
Q42914114	Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts
Q33887672	Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts
Q37002682	Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis
Q34698821	Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines
Q42028739	Cardiovascular Stem Cells in Regenerative Medicine: Ready for Prime Time?
Q41367762	Cardiovascular repair with bone marrow-derived cells
Q38039022	Cardiovascular surgery for realization of regenerative medicine
Q53508391	Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.
Q37399999	Cell delivery and tracking in post-myocardial infarction cardiac stem cell therapy: an introduction for clinical researchers
Q42605371	Cell memory-based therapy
Q42697434	Cell therapies and regenerative medicine - the dawn of a new age or more hype than hope?
Q37444377	Cell therapies for therapeutic angiogenesis: back to the bench
Q37766153	Cell therapy for acute myocardial infarction--where do we go from here?
Q79442807	Cell therapy for cardiac disease: where do we go from here?
Q36304220	Cell therapy for cardiovascular disease: what cells, what diseases and for whom?
Q38095938	Cell therapy for cardiovascular diseases
Q27001159	Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions
Q37776514	Cell therapy for heart failure: the need for a new therapeutic strategy
Q38226693	Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences.
Q37206495	Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells
Q33295408	Cell therapy in congestive heart failure
Q88618933	Cell therapy trials for heart regeneration - lessons learned and future directions
Q37388609	Cell therapy with bone marrow cells for myocardial regeneration
Q37187645	Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction
Q35589728	Cell tracking in cardiac repair: what to image and how to image.
Q35932397	Cell transplantation for myocardial regeneration: hype or reality?
Q53775191	Cell transplantation in heart failure: where do we stand in 2016?
Q82470535	Cell treatment after acute myocardial infarction prevents early decline in circulating IGF-1
Q58555709	Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies
Q36667275	Cell-based approaches for cardiac repair
Q36710763	Cell-based gene therapy for the prevention and treatment of cardiac dysfunction
Q35874249	Cell-based myocardial repair: how should we proceed?
Q40273604	Cell-based therapies after myocardial injury
Q36277263	Cell-based therapies and imaging in cardiology
Q33713519	Cell-based therapy for heart disease: a clinically oriented perspective
Q36176132	Cell-based therapy for prevention and reversal of myocardial remodeling
Q38068940	Cell-based vasculogenic studies in preclinical models of chronic myocardial ischaemia and hibernation.
Q41871395	Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction
Q35847332	Cellular approaches to tissue repair in cardiovascular disease: the more we know, the more there is to learn
Q37638266	Cellular cardiomyoplasty and cardiac regeneration
Q36669952	Cellular cardiomyoplasty by catheter-based infusion of stem cells in clinical settings
Q36236544	Cellular cardiomyoplasty for myocardial regeneration
Q38027920	Cellular cardiomyoplasty: current state of the field.
Q35895936	Cellular recruitment and the development of the myocardium
Q37687140	Cellular therapy for repair of cardiac damage after acute myocardial infarction
Q84606827	Central Role for Disabled-2 in Mesenchymal Stem Cardiac Protein Expression and Functional Consequences After Engraftment in Acute Myocardial Infarction
Q28083859	Challenges in identifying the best source of stem cells for cardiac regeneration therapy
Q37731741	Challenges in the translation of cardiovascular cell therapy
Q38059068	Challenges measuring cardiomyocyte renewal
Q50634035	Challenging the cardiac differentiation of bone marrow cells: a clinical perspective.
Q35770827	Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention
Q57072502	Changing Metabolism in Differentiating Cardiac Progenitor Cells-Can Stem Cells Become Metabolically Flexible Cardiomyocytes?
Q51016542	Characterization of ion currents of murine CD117(pos) stem cells in vitro and their modulation under AT2 R stimulation.
Q38360697	Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium.
Q38669503	Chasing c-Kit through the heart: Taking a broader view
Q34625604	Chemokines and inflammation in heart disease: adaptive or maladaptive?
Q54561747	Chimerism and microchimerism of the human heart: evidence for cardiac regeneration.
Q36362635	Chronic High-Fat Feeding Affects the Mesenchymal Cell Population Expanded From Adipose Tissue but Not Cardiac Atria.
Q43189856	Circulating around the tissue: hematopoietic cell-based fusion versus transdifferentiation
Q37235933	Circulating endothelial cells as biomarkers of prostate cancer.
Q33737172	Circulating smooth muscle progenitor cells in arterial remodeling
Q37783940	Clinical Application of Stem Cells in the Cardiovascular System
Q38114986	Clinical application of adult stem cells for therapy for cardiac disease
Q49029956	Clinical impact of combined transplantation of autologous skeletal myoblasts and bone marrow mononuclear cells in patients with severely deteriorated ischemic cardiomyopathy
Q33777861	Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction
Q46767299	Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography
Q50569820	Co-culture with cardiomyocytes enhanced the myogenic conversion of mesenchymal stromal cells in a dose-dependent manner.
Q36127880	Coculture with hematopoietic stem cells protects cardiomyocytes against apoptosis via paracrine activation of AKT
Q38926005	Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation.
Q34046814	Combinatorial G-CSF/AMD3100 treatment in cardiac repair after myocardial infarction
Q28478584	Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation
Q45888303	Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction
Q38206163	Combined usage of stem cells in end-stage heart failure therapies
Q55053507	Combining censored and uncensored data in a U-statistic: design and sample size implications for cell therapy research.
Q53537945	Comparison of cell therapy and cytokine therapy for functional repair in ischemic and nonischemic heart failure.
Q36853991	Comparison of different adult stem cell types for treatment of myocardial ischemia
Q36990545	Comparison of the direct effects of human adipose- and bone-marrow-derived stem cells on postischemic cardiomyoblasts in an in vitro simulated ischemia-reperfusion model
Q34977853	Composite scaffold provides a cell delivery platform for cardiovascular repair
Q50770130	Composite tissue transplantation in rats: fusion of donor muscle to the recipient site.
Q51869600	Computational modeling for the optimization of a cardiogenic 3D bioprocess of encapsulated embryonic stem cells.
Q27021931	Concise review: heart regeneration and the role of cardiac stem cells
Q38174052	Concise review: skeletal muscle stem cells and cardiac lineage: potential for heart repair.
Q50644699	Connexin 40 promoter-based enrichment of embryonic stem cell-derived cardiovascular progenitor cells.
Q36406455	Contemplating the bright future of stem cell therapy for cardiovascular disease
Q34717227	Contribution of bone marrow-derived hematopoietic stem/progenitor cells to the generation of donor-marker⁺ cardiomyocytes in vivo.
Q37521994	Contribution of human hematopoietic stem cells to liver repair.
Q45644333	Cord blood cell therapy alters LV remodeling and cytokine expression but does not improve heart function after myocardial infarction in rats
Q35391492	Coronary artery ligation and intramyocardial injection in a murine model of infarction
Q37534988	Coronary vessel development and insight towards neovascular therapy.
Q53859054	Correlation between Therapeutic Efficacy of CD34+ Cell Treatment and Directed In Vivo Angiogenesis in Patients with End-Stage Diffuse Coronary Artery Disease.
Q64274926	Cortical Bone Derived Stem Cells for Cardiac Wound Healing
Q39381566	Crosstalk between Stem and Progenitor Cellular Mediators with Special Emphasis on Vasculogenesis.
Q24810258	Culture of skeletal myoblasts from human donors aged over 40 years: dynamics of cell growth and expression of differentiation markers
Q34363654	Cultured human bone marrow-derived CD31(+) cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects
Q46936262	Current outlook of cardiac stem cell therapy towards a clinical application
Q37731746	Current perspectives on imaging cardiac stem cell therapy
Q38090542	Current status of cell-based therapy for heart failure
Q40442893	Current status of myocardial regeneration and cell transplantation
Q38058287	Current status of myocardial regeneration therapy
Q35623878	Current status of stem cell therapy in heart failure
Q27004753	Current stem cell delivery methods for myocardial repair
Q41540397	Cytoglobin Promotes Cardiac Progenitor Cell Survival against Oxidative Stress via the Upregulation of the NFκB/iNOS Signal Pathway and Nitric Oxide Production
Q53628210	Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury.
Q39032257	Dating the Heart: Exploring Cardiomyocyte Renewal in Humans
Q34271595	De novo myocardial regeneration: advances and pitfalls
Q30493641	Delayed enrichment of mesenchymal cells promotes cardiac lineage and calcium transient development
Q34248666	Delivery and tracking of therapeutic cell preparations for clinical cardiovascular applications.
Q82662246	Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny
Q43253690	Design of a 3D aligned myocardial tissue construct from biodegradable polyesters
Q30355871	Detection of intramyocardially injected DiR-labeled mesenchymal stem cells by optical and optoacoustic tomography
Q35600453	Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury
Q33824505	Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).
Q28080127	Developmental origin and lineage plasticity of endogenous cardiac stem cells
Q34617338	Diabetes and aging alter bone marrow contributions to tissue maintenance
Q38970690	Different responses of influenza epidemic to weather factors among Shanghai, Hong Kong, and British Columbia
Q43272453	Differential ability of somatic stem cells.
Q81123128	Differential myocardial infarct repair with muscle stem cells compared to myoblasts
Q47575065	Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats.
Q58816270	Differentiation of circulating endothelial progenitor cells to a cardiomyogenic phenotype depends on E-cadherin
Q35236178	Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium
Q48697095	Divergent cell cycle kinetics of midgestation ventricular cells entail a higher engraftment efficiency after cell transplantation
Q33755185	Diverging Concepts and Novel Perspectives in Regenerative Medicine.
Q36918318	Do stem cells in the heart truly differentiate into cardiomyocytes?
Q29304005	Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response
Q36814737	Donor cell transplantation for myocardial disease: does it complement current pharmacological therapies?
Q33452242	Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure
Q47573004	Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarction.
Q36898800	Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy.
Q30531405	Dynamic clonal analysis of murine hematopoietic stem and progenitor cells marked by 5 fluorescent proteins using confocal and multiphoton microscopy
Q35639803	Dynamics of proteins in Golgi membranes: comparisons between mammalian and plant cells highlighted by photobleaching techniques.
Q36739783	Early management of ST elevation myocardial infarction: a review of practice
Q43270064	Effect of 5-azacytidine induction duration on differentiation of human first-trimester fetal mesenchymal stem cells towards cardiomyocyte-like cells
Q36894836	Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study--A Single-Center, Blinded, Randomized Controlled Trial
Q46968356	Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells
Q34062678	Effect of disruption of Akt-1 of lin(-)c-kit(+) stem cells on myocardial performance in infarcted heart
Q87345457	Effects of Ca2+-activated potassium and inward rectifier potassium channel on the differentiation of endothelial progenitor cells from human peripheral blood
Q36371225	Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction
Q82662237	Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans
Q35290282	Efficacy and safety of bone marrow cell transplantation for chronic ischemic heart disease: a meta-analysis
Q33607929	Efficacy and safety of intracoronary autologous bone marrow-derived cell transplantation in patients with acute myocardial infarction: insights from randomized controlled trials with 12 or more months follow-up.
Q47722619	Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells
Q43120358	Efficient siRNA delivery by the cationic liposome DOTAP in human hematopoietic stem cells differentiating into dendritic cells
Q40139872	Efficient transient genetic labeling of human CD34+ progenitor cells for in vivo application
Q47583837	Electrical coupling between ventricular myocytes and myofibroblasts in the infarcted mouse heart
Q40301895	Electrical effects of stem cell transplantation for ischaemic cardiomyopathy: friend or foe?
Q52681668	Embryonic Stem Cell-Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic-Ischemic Mouse Brain.
Q35201621	Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration
Q36995124	Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions
Q37388612	Embryonic stem cells in cardiac repair and regeneration
Q80833914	Embryonic stem cells pace the heart
Q36920724	Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology
Q34239856	Empowering adult stem cells for myocardial regeneration
Q42090077	Endothelial cells contribute to generation of adult ventricular myocytes during cardiac homeostasis
Q35985560	Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance.
Q37325660	Endothelial progenitor cells: implications for cardiovascular disease
Q36387870	Endothelial-cardiomyocyte interactions in cardiac development and repair
Q34508414	Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts
Q35747710	Engineered myocardial tissues constructed in vivo using cardiomyocyte-like cells derived from bone marrow mesenchymal stem cells in rats
Q36804669	Engineering stem cells for therapy
Q59064296	Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia
Q24677311	Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium
Q39848465	Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery
Q39864941	Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy
Q36121810	Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair
Q43593323	Epicardial progenitor cells in cardiac regeneration and neovascularisation
Q38930599	Epicardium-Derived Heart Repair.
Q37513850	Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs
Q46568661	Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia
Q39864835	Estrogen receptor alpha supports cardiomyocytes indirectly through post-infarct cardiac c-kit+ cells
Q50868250	Evaluating the role of autologous mesenchymal stem cell seeded on decellularized pericardium in the treatment of myocardial infarction: an animal study.
Q37273936	Evidence that bone marrow cells do not contribute to the alveolar epithelium
Q40018932	Evolution of the c-kit-positive cell response to pathological challenge in the myocardium
Q47438101	Evolving cell-based therapies for heart failure patients
Q37358894	Ex vivo nanofiber expansion and genetic modification of human cord blood-derived progenitor/stem cells enhances vasculogenesis.
Q59795422	Exosomes: Basic Biology and Technological Advancements Suggesting Their Potential as Ischemic Heart Disease Therapeutics
Q45831019	Expansion of Umbilical Cord Blood Aldehyde Dehydrogenase Expressing Cells Generates Myeloid Progenitor Cells that Stimulate Limb Revascularization
Q28073078	Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery
Q38195538	Extra- and intracellular factors regulating cardiomyocyte proliferation in postnatal life.
Q38292668	Extracellular vesicles: potential roles in regenerative medicine
Q36942196	FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarction
Q33842934	FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes.
Q27309113	Fetal myocardium in the kidney capsule: an in vivo model of repopulation of myocytes by bone marrow cells
Q37120596	Finding Expandable Induced Cardiovascular Progenitor Cells
Q55229425	Forging the Fate of Cellular Therapies for Cardiovascular Disease.
Q35221817	Formation of human myocardium in the rat heart from human embryonic stem cells
Q36569726	From cardiac repair to cardiac regeneration--ready to translate?
Q49423373	Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro
Q50977973	Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation.
Q35539690	Functional and transcriptomic recovery of infarcted mouse myocardium treated with bone marrow mononuclear cells.
Q51621930	Functional impact of targeted closed-chest transplantation of bone marrow cells in rats with acute myocardial ischemia/reperfusion injury.
Q50648691	Functional properties of cells obtained from human cord blood CD34+ stem cells and mouse cardiac myocytes in coculture.
Q38000518	Functional screening of intracardiac cell transplants using two-photon fluorescence microscopy.
Q51712826	Fusion of circulating blood cells with solid-organ tissue cells in clinical stem cell transplants: a potential therapeutic model?
Q81424114	G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes
Q37176449	G-CSF- and erythropoietin-based cell therapy: a promising strategy for angiomyogenesis in myocardial infarction
Q36227832	G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis
Q38660472	Gaining myocytes or losing fibroblasts: Challenges in cardiac fibroblast reprogramming for infarct repair
Q35606632	Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1).
Q26865425	Gene and cell therapies for the failing heart to prevent sudden arrhythmic death
Q36675432	Gene and cell therapy for chronic ischaemic heart disease
Q37470623	Gene and cell therapy for heart failure
Q39136745	Generation of induced cardiac progenitor cells via somatic reprogramming
Q36982525	Genesis of myocardial repair with cardiac progenitor cells and tissue engineering
Q34298871	Genetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy
Q37156670	Genetic enhancement of stem cell engraftment, survival, and efficacy
Q37010620	Genetic modification of stem cells for transplantation
Q39871712	Genomic profiling of developing cardiomyocytes from recombinant murine embryonic stem cells reveals regulation of transcription factor clusters
Q36540656	Getting to the heart of myocardial stem cells and cell therapy
Q53318735	Global contractility increment in nonischemic dilated cardiomyopathy after free wall-only intramyocardial injection of autologous bone marrow mononuclear cells: an insight over stem cells clinical mechanism of action.
Q38160044	Global search for right cell type as a treatment modality for cardiovascular disease
Q35644254	Granulocyte colony-stimulating factor treatment plus dipeptidylpeptidase-IV inhibition augments myocardial regeneration in mice expressing cyclin D2 in adult cardiomyocytes
Q53055138	Granulocyte-colony stimulating factor reduces cardiomyocyte apoptosis and ameliorates diastolic dysfunction in Otsuka Long-Evans Tokushima Fatty rats.
Q40250950	Granulocyte-colony-stimulating factor in acute myocardial infarction: future perspectives after FIRSTLINE-AMI and REVIVAL-2.
Q33781018	Growth factors induce the improved cardiac remodeling in autologous mesenchymal stem cell-implanted failing rat hearts
Q38018889	Harnessing the potential of adult cardiac stem cells: lessons from haematopoiesis, the embryo and the niche
Q36029669	Healing a broken heart with stem cells
Q57395528	Heart failure and regenerative cardiology
Q33605156	Heart failure management: the present and the future
Q24562846	Heart regeneration
Q38654054	Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics
Q89870117	Heart regeneration in mouse and human: A bioengineering perspective
Q34390677	Heart regeneration: Past, present and future
Q36606663	Heart repair and stem cells
Q46296118	Heart valve and myocardial tissue engineering
Q43077724	Hearty slices to plan for future health
Q36824005	Hematopoietic stem cells are pluripotent and not just "hematopoietic".
Q37194059	Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia
Q42742754	Heterogeneity of engrafted bone-lining cells after systemic and local transplantation
Q93270242	Heterogenetic parabiosis between healthy and dystrophic mice improve the histopathology in muscular dystrophy
Q35848474	Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines.
Q37353891	Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction
Q41871049	Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells
Q36882814	Human cardiospheres as a source of multipotent stem and progenitor cells
Q50525938	Human cord blood CD34+ progenitor cells acquire functional cardiac properties through a cell fusion process.
Q35085099	Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver
Q40434564	Human embryoid body-derived stem cells in co-culture with bladder smooth muscle and urothelium
Q36804578	Human embryonic stem cell-derived cardiomyocytes: inducing strategies.
Q37911584	Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation
Q37023827	Human embryonic stem cells and cardiac repair
Q40353752	Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell line
Q37554356	Human heart valve-derived scaffold improves cardiac repair in a murine model of myocardial infarction
Q53629452	Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel.
Q34051561	Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease
Q37924272	Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective
Q39847147	Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents.
Q35874256	Human stem cells shape the future of cardiac regeneration research
Q33807191	Human umbilical cord blood mononuclear cell transplantation in rats with intrinsic sphincter deficiency
Q37262399	Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.
Q37075151	Hunt for pluripotent stem cell -- regenerative medicine search for almighty cell
Q37247304	Hyaluronic acid-based hydrogel induces neovascularization and improves cardiac function in a rat model of myocardial infarction
Q37830101	Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion
Q46323076	Hypoxic preconditioning protects rat hearts against ischaemia-reperfusion injury: role of erythropoietin on progenitor cell mobilization
Q27334319	ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction
Q50710399	Identification of interventricular septum precursor cells in the mouse embryo.
Q36124315	Identity deception: not a crime for a stem cell
Q37242779	Imaging gene expression in human mesenchymal stem cells: from small to large animals
Q36656791	Imaging stem cells implanted in infarcted myocardium
Q35879474	Immuno-modification of enhancing stem cells targeting for myocardial repair.
Q51714776	Impact of different bone marrow cell preparations on left ventricular remodelling after experimental myocardial infarction.
Q42548551	Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction
Q33781650	Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease
Q38088809	Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes
Q35163294	Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway
Q31028296	Improvement of cardiac function in mouse myocardial infarction after transplantation of epigenetically-modified bone marrow progenitor cells
Q33753521	Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease
Q38840533	Improving stem cell therapy in cardiovascular diseases: the potential role of microRNA.
Q28069954	Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation?
Q34993682	In situ three-dimensional reconstruction of mouse heart sympathetic innervation by two-photon excitation fluorescence imaging
Q35855818	In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function.
Q35621666	In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium
Q37120197	Increased cardiac myocyte progenitors in failing human hearts
Q48154865	Increases in plasma Tβ4 after intracardiac cell therapy in chronic ischemic heart failure is associated with symptomatic improvement
Q38203865	Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.
Q51743757	Inflammatory responses after intracoronary mononuclear BM cell therapy in swine.
Q47904355	Influence of in vitro biomimicked stem cell 'niche' for regulation of proliferation and differentiation of human bone marrow-derived mesenchymal stem cells to myocardial phenotypes: serum starvation without aid of chemical agents and prevention of s
Q42027651	Initial clinical outcomes of intracoronary infusion of autologous progenitor cells in patients with acute myocardial infarction.
Q37294345	Injectable cardiac tissue engineering for the treatment of myocardial infarction
Q33433387	Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy
Q37606016	Innate regeneration in the aging heart: healing from within
Q41288382	Innervating sympathetic neurons regulate heart size and the timing of cardiomyocyte cell cycle withdrawal
Q33734315	Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue
Q33327638	Intracoronary autologous bone marrow-derived mononuclear cell transplantation improves coronary collateral vessel formation and recruitment capacity in patients with ischemic cardiomyopathy: a combined hemodynamic and scintigraphic approach
Q34332467	Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
Q37598908	Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease
Q34318046	Intracoronary delivery of bone-marrow-derived stem cells
Q33258314	Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis
Q39836735	Intramyocardial Peptide Nanofiber Injection Improves Postinfarction Ventricular Remodeling and Efficacy of Bone Marrow Cell Therapy in Pigs
Q47895605	Intramyocardial delivery of bone marrow mononuclear cells and mechanical assist device implantation in patients with end-stage cardiomyopathy
Q40191474	Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis
Q42659946	Is biological repair of heart on the horizon?
Q44948306	Is heart regeneration on the right track?
Q37408693	Is stem cell-based therapy going on or out for cardiac disease?
Q42456173	Ischaemia/reperfusion induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF-kappaB pathway
Q39109413	Ischemia/Reperfusion
Q36691627	Isolation and expansion of resident cardiac progenitor cells.
Q35882798	It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications
Q38140885	JAK-STAT signaling in cardiomyogenesis of cardiac stem cells
Q34292542	Label-free enrichment of functional cardiomyocytes using microfluidic deterministic lateral flow displacement
Q34090699	LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction
Q33611657	Learning from Mother Nature: Innovative Tools to Boost Endogenous Repair of Critical or Difficult-to-Heal Large Tissue Defects
Q37778540	Lessons for cardiac regeneration and repair through development
Q33328467	Lineage tracing of cardiac explant derived cells.
Q51808978	Liver repopulation trial using bone marrow cells in a retrorsine-induced chronic hepatocellular injury model.
Q37043528	Logistics of stem cell isolation, preparation and delivery for heart repair: concerns of clinicians, manufacturers, investors and public health.
Q41665176	Lost and found: cardiac stem cell therapy revisited
Q59057872	Lost in translation
Q37506545	Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help?
Q34962330	MSCs transplantation with application of G-CSF reduces apoptosis or increases VEGF in rabbit model of myocardial infarction
Q39295052	Macrophages modulate the viability and growth of human mesenchymal stem cells
Q52789420	Mammalian Heart Regeneration: The Race to the Finish Line.
Q27024992	Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes
Q40508379	Mechanical derivation of functional myotubes from adipose-derived stem cells.
Q93147053	Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate
Q90617296	Mesenchymal Stem Cell-Derived Extracellular Vesicles in Tissue Regeneration
Q26785404	Mesenchymal Stem Cells for Cardiac Regenerative Therapy: Optimization of Cell Differentiation Strategy
Q36972669	Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment
Q38069136	Mesenchymal stem cells and kidney repair
Q38816740	Mesenchymal stem cells and vascular regeneration.
Q41983710	Mesenchymal stem cells are recruited to striated muscle by NFAT/IL-4-mediated cell fusion
Q37884436	Mesenchymal stem cells for cardiovascular regeneration
Q44592644	Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation
Q30494495	Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections
Q37296154	Metabolic modulation and cellular therapy of cardiac dysfunction and failure
Q34907048	Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans
Q41683501	Migration and proliferation of human mesenchymal stem cells is stimulated by different regions of the mechano-growth factor prohormone
Q36477618	Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease
Q45871851	Mobilization of haematopoietic and non-haematopoietic cells by granulocyte-colony stimulating factor and vascular endothelial growth factor gene therapy in patients with stable severe coronary artery disease
Q30477168	Molecular Imaging of Stem Cell Transplantation in Myocardial Disease
Q47363128	Molecular medicine: the writing is on the vessel wall
Q37808269	Molecular physiology of cardiac regeneration
Q50660744	Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction.
Q54569449	Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report.
Q54217535	Most of the Dust Has Settled: cKit+ Progenitor Cells Are an Irrelevant Source of Cardiac Myocytes In Vivo.
Q36225111	Multiple stem cell populations contribute to the formation of the myocardium
Q37002713	Multipotency and cardiomyogenic potential of human adipose-derived stem cells from epicardium, pericardium, and omentum
Q63364496	Multipotent Progenitor Cells in Regenerative Cardiovascular Medicine
Q64992007	Multipotent fetal-derived Cdx2 cells from placenta regenerate the heart.
Q42853310	Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment
Q42407370	Multipotent stem cells in cardiac regenerative therapy
Q28085334	Multipotent stem cells of the heart-do they have therapeutic promise?
Q37157338	MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases
Q52730089	Myocardial Polyploidization Creates a Barrier to Heart Regeneration in Zebrafish.
Q48247352	Myocardial Regeneration via Progenitor Cell-Derived Exosomes
Q35727937	Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.
Q38632039	Myocardial infarction: stem cell transplantation for cardiac regeneration.
Q38045804	Myocardial regeneration of the failing heart
Q34402223	Myocardial regeneration with bone-marrow-derived stem cells
Q36247746	Myocardial regenerative properties of macrophage populations and stem cells.
Q35168352	Myocardial remodeling: cellular and extracellular events and targets
Q37176440	Myocardial repair: from salvage to tissue reconstruction
Q33635730	Myocardial survival signaling in response to stem cell transplantation
Q37578552	Myocardial tissue engineering: the quest for the ideal myocardial substitute
Q36304191	Myocardial-cell replacement: the science, the clinic and the future
Q35733632	Myocyte proliferation in the developing heart
Q88540277	Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing
Q38074105	Natural ECM as biomaterial for scaffold based cardiac regeneration using adult bone marrow derived stem cells.
Q39022829	Natural killer cells in inflammatory heart disease.
Q38738993	Navigating the labyrinth of cardiac regeneration
Q36949077	Neoangiogenesis with endothelial precursors for the treatment of ischemia
Q79898170	Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization
Q57176905	New Myocyte Formation in the Adult Heart: Endogenous Sources and Therapeutic Implications
Q38048838	New cell therapies in cardiology.
Q37783802	New therapies for the failing heart: trans-genes versus trans-cells.
Q46197643	New tissue for failing hearts
Q28306609	Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells
Q37907966	Noninvasive stem cell tracking
Q36666478	Nuclear imaging in cardiac cell therapy
Q35841708	On how Rac controls hematopoietic stem cell activity
Q61799559	On the Choice of the Extracellular Vesicles for Therapeutic Purposes
Q41389712	One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction
Q93069246	Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction
Q36054643	Optimized protocol for immunostaining of experimental GFP-expressing and human hearts
Q38982831	Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology
Q37997980	Organ repair and regeneration: an overview.
Q27023325	Origin of cardiomyocytes in the adult heart
Q37488050	Over-expression of HSP47 augments mouse embryonic stem cell smooth muscle differentiation and chemotaxis
Q36415354	Overview of recent advances in molecular cardiology
Q90670550	Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis
Q51011615	Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium.
Q29620571	Paracrine mechanisms in adult stem cell signaling and therapy
Q38107063	Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.
Q42854848	Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells--implications for stem cell therapies in regenerative medicine
Q50528333	Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart.
Q38596702	Pathophysiology of Myocardial Infarction
Q28071643	Peripheral blood mononuclear cell secretome for tissue repair
Q37467729	Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).
Q26765883	Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?
Q46770537	Phenotypic characteristics of hybrid cells produced by cell fusion of porcine adrenal chromaffin cells with human mesenchymal stem cells: a preliminary study
Q50773050	Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapy.
Q37969874	Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?
Q56777886	Plasticity and cardiovascular applications of multipotent adult progenitor cells
Q36667445	Plasticity and tissue regenerative potential of bone marrow-derived cells
Q33875374	Pluripotent stem cell derived cardiomyocytes for cardiac repair
Q36855438	Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends
Q30497438	Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization
Q37016190	Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure
Q53236739	Positron emission tomography for the evaluation and treatment of cardiomyopathy.
Q39069601	Possible Muscle Repair in the Human Cardiovascular System
Q28306800	Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages
Q38160455	Potential and clinical utility of stem cells in cardiovascular disease.
Q36523923	Potential of stem-cell-based therapies for heart disease
Q37382220	Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue
Q36850078	Preconditioning c-Kit-positive Human Cardiac Stem Cells with a Nitric Oxide Donor Enhances Cell Survival through Activation of Survival Signaling Pathways
Q37668953	Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration
Q34276744	Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells
Q50657450	Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells.
Q39440985	Pro-angiogenic potential of human chorion-derived stem cells: in vitro and in vivo evaluation
Q37595834	Progenitor cell therapy for heart disease
Q40457855	Progenitor cell therapy of ischemic heart disease: the new frontier.
Q36108608	Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope?
Q26823933	Programming and reprogramming a human heart cell
Q36327823	Progress and prospects: cell based regenerative therapy for cardiovascular disease.
Q59086575	Prometheus unbound
Q41214335	Promises and pitfalls in cell replacement therapy for heart failure
Q94503644	Promoting Cardiac Regeneration and Repair Using Acellular Biomaterials
Q35639798	Protein localization in the plant Golgi apparatus and the trans-Golgi network
Q38629150	Proteomics of cell-cell interactions in health and disease.
Q54619692	Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats.
Q38143802	Quo Vadis medycyno regeneracyjna?: Quo Vadis Regenerative Medicine?
Q37807086	REVIEW: Stem Cell Therapy in Cardiovascular Disorders
Q33361149	Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone
Q37444118	Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction
Q38147034	Recent advances in heart regeneration
Q36312990	Recent advances in primary percutaneous intervention for acute myocardial infarction
Q39526666	Recent progress in therapeutic angiogenesis
Q34784347	Recombinant neuregulin 1 does not activate cardiomyocyte DNA synthesis in normal or infarcted adult mice.
Q38032473	Regenerating cardiac cells: insights from the bench and the clinic
Q27687840	Regenerating functional heart tissue for myocardial repair
Q36497191	Regenerating new heart with stem cells
Q91691962	Regenerating the field of cardiovascular cell therapy
Q22251075	Regenerating the heart
Q36038854	Regeneration of the heart
Q36462071	Regenerative medicine for cardiovascular disorders-new milestones: adult stem cells
Q38075104	Regenerative medicine for the treatment of heart disease
Q38174769	Regenerative therapy for cardiovascular disease
Q35222931	Rejuvenation: an integrated approach to regenerative medicine
Q37104058	Repairing damaged myocardium: evaluating cells used for cardiac regeneration
Q37774067	Resident cardiac progenitor cells: at the heart of regeneration.
Q36406482	Resident progenitors and bone marrow stem cells in myocardial renewal and repair
Q53419687	Retention of nanoparticles-labeled bone marrow mononuclear cells in the isolated ex vivo perfused heart after myocardial infarction in animal model.
Q34041306	Retention of stemness and vasculogenic potential of human umbilical cord blood stem cells after repeated expansions on PES-nanofiber matrices.
Q37932621	Retrograde delivery of stem cells: promising delivery strategy for myocardial regenerative therapy.
Q37766134	Review of stem cell-based therapy for the treatment of cardiovascular disease
Q37976449	Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells
Q91905110	Role of Adult Tissue-Derived Pluripotent Stem Cells in Bone Regeneration
Q37689954	Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation
Q36294424	Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart
Q37687409	Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy
Q82530867	SCIPIO brings new momentum to cardiac cell therapy
Q52731083	SDF 1-alpha Attenuates Myocardial Injury Without Altering the Direct Contribution of Circulating Cells.
Q42393097	SDF-1:CXCR4 Axis Is Fundamental for Tissue Preservation and Repair
Q90362748	STAT3 for Cardiac Regenerative Medicine: Involvement in Stem Cell Biology, Pathophysiology, and Bioengineering
Q80322388	Searching for reputability: first randomised study on bone-marrow transplantation in the heart
Q37868851	Selecting the optimal cell for kidney regeneration: fetal, adult or reprogrammed stem cells.
Q51632340	Sex of muscle stem cells does not influence potency for cardiac cell therapy.
Q40167706	Shock waves activate in vitro cultured progenitors and precursors of cardiac cell lineages from the human heart
Q38315476	Short-term intermittent administration of CXCR4 antagonist AMD3100 facilitates myocardial repair in experimental myocardial infarction
Q34827093	Single cell gene profiling revealed heterogeneity of paracrine effects of bone marrow cells in mouse infarcted hearts
Q33823725	Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering.
Q35945147	Some notes on stem cell therapy in cardiovascular diseases
Q36426360	Sources of cardiomyocytes for stem cell therapy: an update
Q51067725	Stem Cell Banking and Its Impact on Cardiac Regenerative Medicine.
Q57951496	Stem Cell Therapy for the Broken Heart: Mini-Organ Transplantation
Q35125820	Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box.
Q39329517	Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases.
Q39190689	Stem Cells in Cardiovascular Medicine: the Road to Regenerative Therapies
Q50075212	Stem Cells in Regenerative Cardiology
Q85240790	Stem and progenitor cell-based therapy approaches: current developments on treatment of acute myocardial infarction and chronic ischemic cardiomyopathy
Q37045472	Stem cell differentiation: cardiac repair
Q35002029	Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine
Q34479264	Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction.
Q37991028	Stem cell mediated cardiovascular repair
Q33708216	Stem cell paracrine actions and tissue regeneration
Q36362598	Stem cell research: future implications for internal medicine
Q38098219	Stem cell stimulation of endogenous myocyte regeneration
Q37087315	Stem cell therapies in cardiovascular disease A "realistic" appraisal.
Q34441749	Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment
Q26801514	Stem cell therapy and tissue engineering for correction of congenital heart disease
Q34129904	Stem cell therapy for cardiac dysfunction
Q37401003	Stem cell therapy for cardiac repair
Q37544884	Stem cell therapy for cardiac repair: benefits and barriers
Q36836349	Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology
Q37877423	Stem cell therapy for heart diseases
Q40097837	Stem cell therapy for heart failure: the science and current progress.
Q39850212	Stem cell therapy for ischemic heart disease
Q36529988	Stem cell therapy for ischemic heart disease: beginning or end of the road?
Q35980614	Stem cell therapy for the heart
Q37070968	Stem cell therapy in acute myocardial infarction
Q46963373	Stem cell therapy in postinfarction chronic coronary heart disease
Q35087066	Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease
Q38225999	Stem cell therapy: challenges ahead
Q33348580	Stem cell therapy: pieces of the puzzle
Q36368239	Stem cell transplantation for the treatment of myocardial infarction
Q34315088	Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation
Q35128063	Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation
Q38050281	Stem cell-based therapy for ischemic heart disease.
Q51726662	Stem cell-derived cardiomyocytes after bone marrow and heart transplantation.
Q37293765	Stem cell-mediated natural tissue engineering
Q36228883	Stem cells
Q36842866	Stem cells and cardiac regeneration
Q37766151	Stem cells and cardiac repair: a critical analysis
Q57635832	Stem cells and cardiovascular tissue repair: Mechanism, methods, and clinical applications
Q35910261	Stem cells and muscle diseases.
Q37991771	Stem cells and regenerative medicine - future perspectives
Q35832759	Stem cells and repair of the heart.
Q36428648	Stem cells and their potential relevance to paediatric cardiology
Q38072245	Stem cells and their role in renal ischaemia reperfusion injury
Q36124846	Stem cells as future therapy in cardiology
Q38273056	Stem cells for cardiac regeneration and possible roles of the transforming growth factor-β superfamily
Q33352048	Stem cells for cardiac repair in acute myocardial infarction
Q38124263	Stem cells for cardiac repair: an introduction
Q35109987	Stem cells for cardiac repair: status, mechanisms, and new strategies
Q36225214	Stem cells for cardiomyocyte regeneration: state of the art.
Q37261623	Stem cells for heart cell therapies
Q36446920	Stem cells for the ischaemic heart
Q40006145	Stem cells from in- or outside of the heart: isolation, characterization, and potential for myocardial tissue regeneration
Q39750538	Stem cells in heart failure
Q33863225	Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function
Q37183624	Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies.
Q29614416	Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming
Q36254634	Stem cells: From embryology to cellular therapy? An appraisal of the present state of art.
Q38467240	Stem-cell angiogenesis and regeneration of the heart: review of a saga of 2 decades.
Q82265727	Stem-cell therapy after acute myocardial infarction: the focus should be on those at risk
Q37089732	Stem-cell therapy for cardiac disease
Q37164041	Stem-cell-based therapy and lessons from the heart
Q37255265	Stemming heart failure with cardiac- or reprogrammed-stem cells
Q34372277	Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction
Q36380582	Strategies for developing therapeutic application of human embryonic stem cells.
Q37162061	Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation
Q46970615	Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure
Q37345060	Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction
Q40054505	Surgical and immune reconstitution murine models in bone marrow research: Potential for exploring mechanisms in sepsis, trauma and allergy
Q36663081	Surgically relevant aspects of stem cell paracrine effects
Q27024287	Systems-based technologies in profiling the stem cell molecular framework for cardioregenerative medicine
Q40476983	THY-1 receptor expression differentiates cardiosphere-derived cells with divergent cardiogenic differentiation potential.
Q47644462	TRPC3-mediated Ca2+ signals as a promising strategy to boost therapeutic angiogenesis in failing hearts: The role of autologous endothelial colony forming cells
Q89801635	Targeting Age-Related Pathways in Heart Failure
Q36642702	Targeting angiogenesis versus myogenesis with cardiac cell therapy
Q37220758	Targeting human CD34+ hematopoietic stem cells with anti-CD45 x anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction
Q38234910	Targeting pleiotropic signaling pathways to control adult cardiac stem cell fate and function.
Q47862843	Telomere-independent cellular senescence in human fetal cardiomyocytes
Q37776212	Teratomas from pluripotent stem cells: A clinical hurdle
Q39067173	The ATP-Binding Cassette Transporter BCRP1/ABCG2 Plays a Pivotal Role in Cardiac Repair After Myocardial Infarction Via Modulation of Microvascular Endothelial Cell Survival and Function
Q52322793	The Delta Opioid Peptide DADLE Represses Hypoxia-Reperfusion Mimicked Stress Mediated Apoptotic Cell Death in Human Mesenchymal Stem Cells in Part by Downregulating the Unfolded Protein Response and ROS along with Enhanced Anti-Inflammatory Effect.
Q39095681	The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin' Away
Q38746402	The Heart and Great Vessels
Q92128776	The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity
Q58998678	The Systems Biology of Stem Cell Released Molecules—Based Therapeutics
Q61443241	The biochemical and electrophysiological profiles of amniotic fluid-derived stem cells following Wnt signaling modulation cardiac differentiation
Q36836344	The birth of 'regenerative pharmacology': a clinical perspective
Q36174197	The bone marrow--cardiac axis of myocardial regeneration
Q30493876	The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction
Q34026411	The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells
Q38375149	The duality of chemokines in heart failure
Q35079018	The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion.
Q26746647	The emerging role of viral vectors as vehicles for DMD gene editing
Q36559150	The future of cell therapy for myocardial regeneration
Q37790961	The future of regenerating the myocardium
Q35092172	The heterogeneous murine corneal stromal cell populations in vitro.
Q36944120	The immature heart: the roles of bone marrow stromal stem cells in growth and myocardial repair
Q37096652	The immune system and cardiac repair.
Q44113705	The importance of understanding the molecular mechanism of stem cell-induced cardiac tissue repair
Q36769987	The magic behind stem cells
Q34629634	The mouse as a model system to study cardiac regeneration
Q38033889	The need for standardized protocols for future clinical trials of cell therapy
Q37839779	The origin of interstitial myofibroblasts in chronic kidney disease
Q37567542	The possible use of stem cells in regenerative medicine: dream or reality?
Q37988002	The regenerative potential of angiotensin AT2 receptor in cardiac repair.
Q34405511	The role of stem cells in cardiac regeneration.
Q37067647	The role of stem cells in the post-MI patient
Q33278687	The stem cell continuum: cell cycle, injury, and phenotype lability
Q36667426	The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells
Q35874253	The strength of plasticity: stem cells for cardiac repair
Q28247457	The stuttering progress of cell therapy for heart disease
Q37053163	The therapeutic potential of stem cells in heart disease
Q51167242	The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium.
Q39580194	The use of stem cells for the repair of cardiac tissue in ischemic heart disease
Q36406459	The utility of magnetic resonance imaging in cardiac tissue regeneration trials
Q47763374	Therapeutic Potential of Hematopoietic Stem Cell-Derived Exosomes in Cardiovascular Disease.
Q37608469	Therapeutic angiogenesis for coronary artery disease: clinical trials of proteins, plasmids, adenovirus and stem cells
Q81140463	Therapeutic angiogenesis gains a leg to stand on
Q36847077	Therapeutic angiogenesis with bone marrow--derived stem cells
Q36909360	Therapeutic potential of adult progenitor cells in cardiovascular disease
Q42121480	Therapeutic potential of human adipose stem cells in a rat myocardial infarction model
Q28295270	Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair
Q38013063	Thymosin β4 and cardiac regeneration: are we missing a beat?
Q38857237	Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?
Q40199212	Tissue engineering approaches for the development of a contractile cardiac patch.
Q37788417	Tissue regeneration potential in human umbilical cord blood
Q33537670	Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
Q29394460	Towards regenerative therapy for cardiac disease
Q37946759	Towards the generation of patient-specific patches for cardiac repair.
Q84570135	Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience
Q40334464	Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation
Q38267322	Transcutaneous measurement of glomerular filtration rate in small rodents: through the skin for the win?
Q26860340	Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement
Q35995055	Translational aspects of cardiac cell therapy
Q52729630	Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types.
Q42379231	Transplantation of Isl1+ cardiac progenitor cells in small intestinal submucosa improves infarcted heart function.
Q81228975	Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study
Q42824750	Transplantation of microencapsulated cells expressing VEGF improves angiogenesis in implanted xenogeneic acellular dermis on wound
Q34702508	Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function
Q46097112	Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction
Q37625948	Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle.
Q50747193	Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure.
Q64243699	Treatment with mononuclear cell populations improves post-infarction cardiac function but does not reduce arrhythmia susceptibility
Q59091693	US government halts heart stem-cell study
Q87297024	Ultrasound targeted microbubble destruction promotes angiogenesis and heart function by inducing myocardial microenvironment change
Q36438947	Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres
Q61479658	Umbilical Cord Blood-Derived Stem Cells Spontaneously Express Cardiomyogenic Traits
Q83220060	Umbilical cord blood cell transplantation for myocardial regeneration
Q50664911	Umbilical cord blood-derived progenitor cells enhance muscle regeneration in mouse hindlimb ischemia model.
Q36804511	Umbilical cord-derived stem cells for tissue therapy: current and future uses
Q33683767	Unchain my heart: the scientific foundations of cardiac repair
Q57823657	Undeniable Evidence That the Adult Mammalian Heart Lacks an Endogenous Regenerative Stem Cell
Q36126866	Update on the use of stem cells for cardiac disease
Q39926156	Use of ferumoxides for stem cell labeling
Q53486196	Uterine cells-an immunoprivileged cell source for therapy-but are they for everyone?
Q45127736	Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo
Q35215645	Very small embryonic-like (VSEL) stem cells in adult organs and their potential role in rejuvenation of tissues and longevity
Q37155637	Very small embryonic-like (VSEL) stem cells: purification from adult organs, characterization, and biological significance
Q37824871	Very small embryonic-like stem cells: biology and therapeutic potential for heart repair
Q83144947	[Embryonic stem cells. Future perspectives]
Q53608261	[Future perspectives in the treatment of heart failure: from cell transplantation to cardiac regeneration].
Q80260743	[Investigation in stem cells]
Q81567481	[Regenerative medicine with adult stem cells]
Q82930966	[Stem cell therapy for the regeneration of heart muscle]
Q84563741	[Surgical intramyocardial stem cell therapy for chronic ischemic heart failure]
Q36484631	beta(1)- and beta(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart
Q34004496	c-Kit+ bone marrow stem cells differentiate into functional cardiac myocytes.
Q46798182	c-kit(+) cells adopt vascular endothelial but not epithelial cell fates during lung maintenance and repair.
Q38313140	c-kit(+) cells: the tell-tale heart of cardiac regeneration?
Q34021586	c-kit+ cells minimally contribute cardiomyocytes to the heart
Q36170830	c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart
Q27315833	c-kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signalling
Q41950391	mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression.
Q34013292	p27 kip1 haplo-insufficiency improves cardiac function in early-stages of myocardial infarction by protecting myocardium and increasing angiogenesis by promoting IKK activation

P6179	Dimensions Publication ID	1012041829
P356	DOI	10.1038/NATURE02446
P698	PubMed publication ID	15034593

P50	author	Jitka A Virag	Q59683766
		Kishore Pasumarthi	Q72249210
P2093	author name string	David A Williams
		Charles E Murry
		Michael Rubart
		Loren J Field
		Hans Reinecke
		Hidehiro Nakajima
		Joshua D Dowell
		Mark H Soonpaa
		Veronica Poppa
		Stephen H Bartelmez
		Hisako O Nakajima
		Gillian Bradford
P2860	cites work	Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice	Q77378087
		Chimerism of the transplanted heart	Q77452324
		Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts	Q77885470
		Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells	Q24672061
		Generalized potential of adult neural stem cells	Q28145509
		Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell	Q28188430
		Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes	Q28209232
		Bone marrow cells regenerate infarcted myocardium	Q28210640
		Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)	Q28216990
		Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans	Q31113632
		Physiological Coupling of Donor and Host Cardiomyocytes After Cellular Transplantation	Q31141231
		Cardiomyocyte regeneration from circulating bone marrow cells in mice	Q31148531
		From marrow to brain: expression of neuronal phenotypes in adult mice.	Q33926766
		Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow	Q33926770
		Myocyte and myogenic stem cell transplantation in the heart	Q35131739
		Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair	Q35843221
		Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction	Q36349782
		Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting	Q45711148
		Immune response to green fluorescent protein: implications for gene therapy	Q45861644
		Muscle regeneration by bone marrow-derived myogenic progenitors	Q45885806
		Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.	Q46003277
		Transdifferentiation of Blood-Derived Human Adult Endothelial Progenitor Cells Into Functionally Active Cardiomyocytes	Q60723059
		Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium	Q72321699
		Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients	Q73106026
		Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart	Q73927431
		Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts	Q74397725
P433	issue	6983
P407	language of work or name	English	Q1860
P304	page(s)	664-668
P577	publication date	2004-03-21
P1433	published in	Nature	Q180445
P1476	title	Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
P478	volume	428

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

scientific article published in Nature

Reverse relations